Loading insider details...
Beta
Latest Form 4 (Jul 6, 2026): Other (see footnotes) of 132 LGND shares, $21.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Other (see footnotes) | 132 | $21.2K |
| Jun 15, 2026 | Pelthos Therapeutics Inc. (PTHS) | Purchase | 35,445 | $985.5K |
| Jun 12, 2026 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/Award | 3,000 | n/a |
| Apr 1, 2026 | Pelthos Therapeutics Inc. (PTHS) | Grant/Award | 12,900 | n/a |
| Mar 28, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 10,495 | n/a |
| Feb 18, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 20,782 | n/a |
| Dec 9, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Gift | 130 | n/a |
| Jul 8, 2025 | Pelthos Therapeutics Inc. (PTHS) | Grant/Award | 19,108 | n/a |
| Jul 4, 2025 | Pelthos Therapeutics Inc. (PTHS) | Conversion | 1,500,000 | $15.00M |
| Jul 2, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Other (see footnotes) | 233 | $21.2K |